1887

Abstract

Cytomegalovirus (CMV) has evolved multiple immunological evasion strategies, including the encoding of viral interleukin (IL)-10 homologues (cmvIL-10). In this study, cmvIL-10 bound avidly to the same receptors on blood mononuclear cells and was as bio-potent as native human IL-10. Seventeen percent of plasma samples from 3200 Danish blood donors (corresponding to 28 % of the anti-CMV IgG-positive donors) contained substantial levels of anti-cmvIL-10 IgG antibodies, as measured by a radioimmunoassay for human anti-cmvIL-10 antibodies. The antibodies neither cross-reacted with native human IL-10 nor with Epstein–Barr virus-encoded IL-10. Anti-cmvIL-10 antibodies potently inhibited the binding of cmvIL-10 to cellular receptors, and they specifically inhibited cmvIL-10-induced JAK–STAT signalling. Ultimately, anti-cmvIL-10 antibodies blocked the inhibitory effect of cmvIL-10 on lipopolysaccharide-induced tumour necrosis factor alpha and IL-1β from blood mononuclear cells. Taken together, our data signify that cmvIL-10 has been produced during CMV infection, and that anti-cmvIL-10 IgG antibodies represent an effective immunological counter reaction against cmvIL-10.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.028738-0
2011-07-01
2019-10-22
Loading full text...

Full text loading...

/deliver/fulltext/jgv/92/7/1508.html?itemId=/content/journal/jgv/10.1099/vir.0.028738-0&mimeType=html&fmt=ahah

References

  1. Bego M. G. , St Jeor S. . ( 2006; ). Human cytomegalovirus infection of cells of hematopoietic origin: HCMV-induced immunosuppression, immune evasion, and latency. . Exp Hematol 34:, 555–570. [CrossRef].[PubMed]
    [Google Scholar]
  2. Bendtzen K. , Hansen M. B. , Ross C. , Svenson M. . ( 2000; ). Detection of autoantibodies to cytokines. . Mol Biotechnol 14:, 251–261. [CrossRef].[PubMed]
    [Google Scholar]
  3. Cheung T. W. , Teich S. A. . ( 1999; ). Cytomegalovirus infection in patients with HIV infection. . Mt Sinai J Med 66:, 113–124.[PubMed]
    [Google Scholar]
  4. Couper K. N. , Blount D. G. , Riley E. M. . ( 2008; ). IL-10: the master regulator of immunity to infection. . J Immunol 180:, 5771–5777.[PubMed] [CrossRef]
    [Google Scholar]
  5. Crough T. , Khanna R. . ( 2009; ). Immunobiology of human cytomegalovirus: from bench to bedside. . Clin Microbiol Rev 22:, 76–98. [CrossRef].[PubMed]
    [Google Scholar]
  6. de Lemos Rieper C. , Galle P. , Hansen M. B. . ( 2009; a). Characterization and potential clinical applications of autoantibodies against cytokines. . Cytokine Growth Factor Rev 20:, 61–75. [CrossRef].[PubMed]
    [Google Scholar]
  7. de Lemos Rieper C. , Galle P. , Svenson M. , Pedersen B. K. , Hansen M. B. . ( 2009; b). Preparation and validation of radio iodinated recombinant human IL-10 for the measurement of natural human antibodies against IL-10. . J Immunol Methods 350:, 46–53. [CrossRef].[PubMed]
    [Google Scholar]
  8. de Lemos Rieper C. , Galle P. , Pedersen B. K. , Hansen M. B. . ( 2010; ). A state of acquired IL-10 deficiency in 0.4% of Danish blood donors. . Cytokine 51:, 286–293. [CrossRef].[PubMed]
    [Google Scholar]
  9. de Waal Malefyt R. , Haanen J. , Spits H. , Roncarolo M. G. , te Velde A. , Figdor C. , Johnson K. , Kastelein R. , Yssel H. , de Vries J. E. . ( 1991; ). Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. . J Exp Med 174:, 915–924. [CrossRef].[PubMed]
    [Google Scholar]
  10. Drew W. L. . ( 1988; ). Diagnosis of cytomegalovirus infection. . Rev Infect Dis 10: Suppl 3 S468–S476. [CrossRef].[PubMed]
    [Google Scholar]
  11. Falagas M. E. , Snydman D. R. , Ruthazer R. , Griffith J. , Werner B. G. , Freeman R. , Rohrer R. . ( 1997; ). Cytomegalovirus immune globulin (CMVIG) prophylaxis is associated with increased survival after orthotopic liver transplantation. . The Boston Center for Liver Transplantation CMVIG Study Group. Clin Transplant 11:, 432–437.[PubMed]
    [Google Scholar]
  12. Finlay B. B. , McFadden G. . ( 2006; ). Anti-immunology: evasion of the host immune system by bacterial and viral pathogens. . Cell 124:, 767–782. [CrossRef].[PubMed]
    [Google Scholar]
  13. Griffiths P. D. , Walter S. . ( 2005; ). Cytomegalovirus. . Curr Opin Infect Dis 18:, 241–245. [CrossRef].[PubMed]
    [Google Scholar]
  14. Hansen M. B. , Svenson M. , Abell K. , Yasukawa K. , Diamant M. , Bendtzen K. . ( 1995; ). Influence of interleukin-6 (IL-6) autoantibodies on IL-6 binding to cellular receptors. . Eur J Immunol 25:, 348–354. [CrossRef].[PubMed]
    [Google Scholar]
  15. Hislop A. D. , Taylor G. S. , Sauce D. , Rickinson A. B. . ( 2007; ). Cellular responses to viral infection in humans: lessons from Epstein–Barr virus. . Annu Rev Immunol 25:, 587–617. [CrossRef].[PubMed]
    [Google Scholar]
  16. Jenkins C. , Abendroth A. , Slobedman B. . ( 2004; ). A novel viral transcript with homology to human interleukin-10 is expressed during latent human cytomegalovirus infection. . J Virol 78:, 1440–1447. [CrossRef].[PubMed]
    [Google Scholar]
  17. Jenkins C. , Garcia W. , Abendroth A. , Slobedman B. . ( 2008; ). Expression of a human cytomegalovirus latency-associated homolog of interleukin-10 during the productive phase of infection. . Virology 370:, 285–294. [CrossRef].[PubMed]
    [Google Scholar]
  18. Jones B. C. , Logsdon N. J. , Josephson K. , Cook J. , Barry P. A. , Walter M. R. . ( 2002; ). Crystal structure of human cytomegalovirus IL-10 bound to soluble human IL-10R1. . Proc Natl Acad Sci U S A 99:, 9404–9409. [CrossRef].[PubMed]
    [Google Scholar]
  19. Kanegane H. , Wakiguchi H. , Kanegane C. , Kurashige T. , Tosato G. . ( 1997; ). Viral interleukin-10 in chronic active Epstein–Barr virus infection. . J Infect Dis 176:, 254–257. [CrossRef].[PubMed]
    [Google Scholar]
  20. Kano Y. , Shiohara T. . ( 2000; ). Current understanding of cytomegalovirus infection in immunocompetent individuals. . J Dermatol Sci 22:, 196–204. [CrossRef].[PubMed]
    [Google Scholar]
  21. Kotenko S. V. , Saccani S. , Izotova L. S. , Mirochnitchenko O. V. , Pestka S. . ( 2000; ). Human cytomegalovirus harbors its own unique IL-10 homolog (cmvIL-10). . Proc Natl Acad Sci U S A 97:, 1695–1700. [CrossRef].[PubMed]
    [Google Scholar]
  22. Lehner P. J. , Wilkinson G. W. . ( 2001; ). Cytomegalovirus: from evasion to suppression?. Nat Immunol 2:, 993–994. [CrossRef].[PubMed]
    [Google Scholar]
  23. Limaye A. P. , Raghu G. , Koelle D. M. , Ferrenberg J. , Huang M. L. , Boeckh M. . ( 2002; ). High incidence of ganciclovir-resistant cytomegalovirus infection among lung transplant recipients receiving preemptive therapy. . J Infect Dis 185:, 20–27. [CrossRef].[PubMed]
    [Google Scholar]
  24. Lin Y. L. , Chang P. C. , Wang Y. , Li M. . ( 2008; ). Identification of novel viral interleukin-10 isoforms of human cytomegalovirus AD169. . Virus Res 131:, 213–223. [CrossRef].[PubMed]
    [Google Scholar]
  25. Lockridge K. M. , Zhou S. S. , Kravitz R. H. , Johnson J. L. , Sawai E. T. , Blewett E. L. , Barry P. A. . ( 2000; ). Primate cytomegaloviruses encode and express an IL-10-like protein. . Virology 268:, 272–280. [CrossRef].[PubMed]
    [Google Scholar]
  26. Menetrier-Caux C. , Briere F. , Jouvenne P. , Peyron E. , Peyron F. , Banchereau J. . ( 1996; ). Identification of human IgG autoantibodies specific for IL-10. . Clin Exp Immunol 104:, 173–179. [CrossRef].[PubMed]
    [Google Scholar]
  27. Moore K. W. , Vieira P. , Fiorentino D. F. , Trounstine M. L. , Khan T. A. , Mosmann T. R. . ( 1990; ). Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein–Barr virus gene BCRFI. . Science 248:, 1230–1234. [CrossRef].[PubMed]
    [Google Scholar]
  28. Moore K. W. , de Waal Malefyt R. , Coffman R. L. , O'Garra A. . ( 2001; ). Interleukin-10 and the interleukin-10 receptor. . Annu Rev Immunol 19:, 683–765. [CrossRef].[PubMed]
    [Google Scholar]
  29. Nigro G. , Adler S. P. , La Torre R. , Best A. M. . Congenital Cytomegalovirus Collaborating Group ( 2005; ). Passive immunization during pregnancy for congenital cytomegalovirus infection. . N Engl J Med 353:, 1350–1362. [CrossRef].[PubMed]
    [Google Scholar]
  30. Rowshani A. T. , Bemelman F. J. , van Leeuwen E. M. , van Lier R. A. , ten Berge I. J. . ( 2005; ). Clinical and immunologic aspects of cytomegalovirus infection in solid organ transplant recipients. . Transplantation 79:, 381–386. [CrossRef].[PubMed]
    [Google Scholar]
  31. Salek-Ardakani S. , Arrand J. R. , Mackett M. . ( 2002; ). Epstein-Barr virus encoded interleukin-10 inhibits HLA-class I, ICAM-1, and B7 expression on human monocytes: implications for immune evasion by EBV. . Virology 304:, 342–351. [CrossRef].[PubMed]
    [Google Scholar]
  32. Sinclair J. . ( 2008; ). Human cytomegalovirus: Latency and reactivation in the myeloid lineage. . J Clin Virol 41:, 180–185. [CrossRef].[PubMed]
    [Google Scholar]
  33. Slobedman B. , Barry P. A. , Spencer J. V. , Avdic S. , Abendroth A. . ( 2009; ). Virus-encoded homologs of cellular interleukin-10 and their control of host immune function. . J Virol 83:, 9618–9629. [CrossRef].[PubMed]
    [Google Scholar]
  34. Snydman D. R. , Werner B. G. , Heinze-Lacey B. , Berardi V. P. , Tilney N. L. , Kirkman R. L. , Milford E. L. , Cho S. I. , Bush H. L. Jr et al. ( 1987; ). Use of cytomegalovirus immune globulin to prevent cytomegalovirus disease in renal-transplant recipients. . N Engl J Med 317:, 1049–1054. [CrossRef].[PubMed]
    [Google Scholar]
  35. Spencer J. V. , Lockridge K. M. , Barry P. A. , Lin G. , Tsang M. , Penfold M. E. , Schall T. J. . ( 2002; ). Potent immunosuppressive activities of cytomegalovirus-encoded interleukin-10. . J Virol 76:, 1285–1292. [CrossRef].[PubMed]
    [Google Scholar]
  36. Spencer J. V. , Cadaoas J. , Castillo P. R. , Saini V. , Slobedman B. . ( 2008; ). Stimulation of B lymphocytes by cmvIL-10 but not LAcmvIL-10. . Virology 374:, 164–169. [CrossRef].[PubMed]
    [Google Scholar]
  37. Tanner J. E. , Diaz-Mitoma F. , Rooney C. M. , Alfieri C. . ( 1997; ). Anti-interleukin-10 antibodies in patients with chronic active Epstein–Barr virus infection. . J Infect Dis 176:, 1454–1461. [CrossRef].[PubMed]
    [Google Scholar]
  38. Vancíková Z. , Dvorák P. . ( 2001; ). Cytomegalovirus infection in immunocompetent and immunocompromised individuals – a review. . Curr Drug Targets Immune Endocr Metabol Disord 1:, 179–187. [CrossRef].[PubMed]
    [Google Scholar]
  39. Yoon S. I. , Jones B. C. , Logsdon N. J. , Walter M. R. . ( 2005; ). Same structure, different function crystal structure of the Epstein–Barr virus IL-10 bound to the soluble IL-10R1 chain. . Structure 13:, 551–564. [CrossRef].[PubMed]
    [Google Scholar]
  40. Zdanov A. . ( 2004; ). Structural features of the interleukin-10 family of cytokines. . Curr Pharm Des 10:, 3873–3884. [CrossRef].[PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.028738-0
Loading
/content/journal/jgv/10.1099/vir.0.028738-0
Loading

Data & Media loading...

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error